MiR-99a inhibits keratinocyte proliferation by targeting Frizzled-5 (FZD5)/FZD8 through β-catenin signaling in psoriasis

被引:18
作者
Shen, Hui [1 ,2 ]
Tian, Yi [1 ]
Yao, Xiaolei [3 ]
Liu, Wen [1 ]
Zhang, Yujin [1 ]
Yang, Zhibo [1 ]
机构
[1] Hunan Univ Chinese Med, Affiliated Hosp 2, Dept Dermatol, Changsha, Hunan, Peoples R China
[2] Guanxi Univ Chinese Med, Ruikang Hosp, Dept Dermatol, Nanning, Guangxi Provinc, Peoples R China
[3] Guanxi Univ Chinese Med, Ruikang Hosp, Dept Ophthalmol, Nanning, Guangxi Provinc, Peoples R China
来源
PHARMAZIE | 2017年 / 72卷 / 08期
基金
中国国家自然科学基金;
关键词
MICRORNAS; BIOMARKERS; EXPRESSION; PATHWAY; CELLS;
D O I
10.1691/ph.2017.7018
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Psoriasis, a common chronic skin disorder, is characterized by hyperproliferation and aberrant differentiation of keratinocytes and infiltration of inflammatory cells into the dermis and epidermis. MicroRNAs (miRNAs) are a large family of highly conserved small non-coding RNA which regulates diverse biological process, including cell proliferation, by modulating gene expression at the posttranscriptional level. In the present study, we indicated that miR-99a was specifically downregulated in psoriatic dermatic lesions, and could inhibit HaCaT cells' proliferation; by direct targeting, miR-99a could also regulate the expression of Frizzled-5 (FZD5)/Frizzled-8 (FZD8). In addition, we found that the downstream factor of FZD5/FZD8 signaling, beta-catenin, and the downstream target gene of beta-catenin, cyclinD1, could be suppressed by miR-99a; the suppressive effect of miR-99a on beta-catenin and cyclinD1 could be partially abolished by forced FZD5/FZD8 expression. Taken together, we assume that miR-99a inhibits HaCaT cells' proliferation by targeting FZD5/FZD8 through downstream factors beta-catenin and cyclinD1, and provide diagnostic markers and a novel target for psoriasis treatment.
引用
收藏
页码:461 / 467
页数:7
相关论文
共 28 条
[1]   Pathobiology of Chronic Inflammatory Skin Diseases: Interplay Between Keratinocytes and Immune Cells as a Target for Anti-Inflammatory Drugs [J].
Albanesi, C. ;
Pastore, S. .
CURRENT DRUG METABOLISM, 2010, 11 (03) :210-227
[2]   Resident skin cells in psoriasis:: a special took at the pathogenetic functions of keratinocytes [J].
Albanesi, Cristina ;
De Pita, Ornella ;
Girolomoni, Giampiero .
CLINICS IN DERMATOLOGY, 2007, 25 (06) :581-588
[3]   MicroRNAs and other tiny endogenous RNAs in C-elegans [J].
Ambros, V ;
Lee, RC ;
Lavanway, A ;
Williams, PT ;
Jewell, D .
CURRENT BIOLOGY, 2003, 13 (10) :807-818
[4]   The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity [J].
Boehncke, Wolf-Henning ;
Boehncke, Sandra ;
Tobin, Anne-Marie ;
Kirby, Brian .
EXPERIMENTAL DERMATOLOGY, 2011, 20 (04) :303-307
[5]   Frizzled receptor dimerization is sufficient to activate the Wnt/β-catenin pathway [J].
Carron, C ;
Pascal, A ;
Djiane, A ;
Boucaut, JC ;
Shi, DL ;
Umbhauer, M .
JOURNAL OF CELL SCIENCE, 2003, 116 (12) :2541-2550
[6]   Lifting the Silver Flakes: The Pathogenesis and Management of Chronic Plaque Psoriasis [J].
Chong, Heng T. ;
Kopecki, Zlatko ;
Cowin, Allison J. .
BIOMED RESEARCH INTERNATIONAL, 2013, 2013
[7]   Wnt/β-catenin signaling in development and disease [J].
Clevers, Hans .
CELL, 2006, 127 (03) :469-480
[8]   Patterns of Wnt/Fzd/LRP Gene Expression During Embryonic Hematopoiesis [J].
Corrigan, Pamela M. ;
Dobbin, Edwina ;
Freeburn, Robin W. ;
Wheadon, Helen .
STEM CELLS AND DEVELOPMENT, 2009, 18 (05) :759-771
[9]   MicroRNAs as therapeutic targets [J].
Czech, MP .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (11) :1194-1195
[10]   RETRACTED: MicroRNA-181b negatively regulates the proliferation of human epidermal keratinocytes in psoriasis through targeting TLR4 (Retracted Article) [J].
Feng, Cheng ;
Bai, Ming ;
Yu, Nan-Ze ;
Wang, Xiao-Jun ;
Liu, Zeng .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (02) :278-285